The Venture Codex Logo

The Venture Codex

Ventura BioMed Investors

Herrnstrasse 44, Munich, 80539, Germany

Overview

Invests in early-stage life science companies and innovative therapies.

Deals · 12mo

1

Links

WebsiteLinkedIn

Stage focus

Seed
Series A

Geographic focus

Germany
Switzerland

Sector focus

—

Investment portfolio

6rounds
NAMEDATESIZE
Kupando
Mar 2026Participated
$12 MSeries A
Nia Health
May 2023Participated
$4 MSeed
Navignostics
Nov 2022Participated
$8 MSeed
IRUBIS
Oct 2022Led
$3 MSeed
Kupando
Sep 2022Participated
$13 MSeries A
Abalos Therapeutics
Oct 2021Participated
$38 MSeries A
Kupando
Mar 2026Participated
$12 MSeries A
Nia Health
May 2023Participated
$4 MSeed
Navignostics
Nov 2022Participated
$8 MSeed
IRUBIS
Oct 2022Led
$3 MSeed
Kupando
Sep 2022Participated
$13 MSeries A
Abalos Therapeutics
Oct 2021Participated
$38 MSeries A
6
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Ventura BioMed Investors: 6 funding rounds are recorded in the selected participation categories.All available history.
Ventura BioMed Investors: 6 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed12
Series A03

Monthly Deal Activity

Ventura BioMed Investors: 6 deals are recorded across 61 months.All available history.
Ventura BioMed Investors: 6 deals are recorded across 61 months. All available history
MonthDeals
Oct '211
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '221
Oct '221
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '231
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '261
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Ventura BioMed Investors: Health & Life Sciences is the largest displayed sector by deal count (6 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Ventura BioMed Investors: Health & Life Sciences is the largest displayed sector by deal count (6 deals). All available history
SectorDeals
Health & Life Sciences6
Space & Frontier Tech1
Consumer & Lifestyle1

Deal Size Distribution

Ventura BioMed Investors: 6 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Ventura BioMed Investors: 6 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M1
$10M-$25M2
$25M-$50M1
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Ventura BioMed Investors: Europe has the largest recorded deal count among the displayed regions (6 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Ventura BioMed Investors: Europe has the largest recorded deal count among the displayed regions (6 deals). All available history
RegionDeals
Europe6
Ventura BioMed Investors: 18 co-investors are shown, with High-Tech Grunderfonds sharing 5 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Ventura BioMed Investors: 18 co-investors are shown, with High-Tech Grunderfonds sharing 5 recorded deals. All available history
Co-investorShared deals
High-Tech Grunderfonds5
Brandenburg Kapital2
LifeCare Partners2
Remiges Ventures2
adesso ventures1
Boehringer Ingelheim1
Bruker1
Carma Fund1
coparion1
EIC Fund1
Gründerfonds Ruhr1
Hx Bio Ventures1
Initiative for Industrial Innovators1
NRW.BANK1
Seventure Partners1
Think.Health Ventures1
Verve Ventures1
Zürcher Kantonalbank1

Investment Strategy

Ventura BioMed Investors: Led accounts for 17% and participating for 83% of round participation.All available history.
Ventura BioMed Investors: Led accounts for 17% and participating for 83% of round participation. All available history
CategoryDeals (count)Share (%)
Led117%
Participating583%
Ventura BioMed Investors: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
Ventura BioMed Investors: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led1100%

Team

Andreas Jenne

CEO